Portfolio Company

AgenT

AgenT has developed two groundbreaking diagnostic tools for Alzheimer’s disease: B-HEALED™ and B-AHEAD™ tests. These tests utilize a panel of patented multi-omics biomarkers (proteins and metabolites) quantified in the blood through 2 proprietary targeted mass spectrometry methods. Advanced machine learning algorithms then interpret these biomarkers to provide a diagnosis.